A Bioequivalence Study of Tobradex AF

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Tobramycin; Tobramycin, Dexamethasone Drug Combination

Criteria

Inclusion Criteria:

• 18 or older

• Other protocol-defined inclusion criteria may apply

Exclusion Criteria:

• Under 18

• Other protocol-defined exclusion criteria may apply